How to Get a GLP-1 Prescription Through Telehealth

GLP-1 receptor agonists — including semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (Mounjaro and Zepbound) — are prescription medications that require evaluation by a licensed healthcare provider. Telehealth has made this process dramatically more accessible, allowing patients to receive a legitimate medical evaluation and prescription entirely online.

The telehealth prescription process mirrors what happens in a traditional doctor's office, minus the waiting room. A licensed provider reviews your medical history, assesses your BMI and weight-related health conditions, checks for contraindications, and determines whether a GLP-1 medication is clinically appropriate. The key difference is efficiency — what might require scheduling an appointment weeks out, taking time off work, and sitting through a 45-minute office visit can be completed in under 10 minutes online.

It is important to understand that telehealth GLP-1 prescriptions are held to the same medical and legal standards as in-person prescriptions. The provider must be licensed in your state, must conduct a bona fide medical evaluation, and must document the clinical rationale for prescribing. At Weight Method, our providers follow evidence-based prescribing protocols aligned with the American Association of Clinical Endocrinology and Obesity Medicine Association guidelines.

The clinical criteria for GLP-1 prescriptions are the same whether you see a provider in person or online. Generally, you may qualify if you have a BMI of 30 or higher (obesity) or a BMI of 27 or higher (overweight) with at least one weight-related comorbidity. Common qualifying conditions include type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, and cardiovascular disease.

There are specific contraindications that may disqualify you from GLP-1 treatment. These include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2 (MEN 2), a history of pancreatitis, or known hypersensitivity to semaglutide or tirzepatide. Pregnant or breastfeeding individuals should not use GLP-1 medications. Patients with severe gastrointestinal conditions like gastroparesis may also need alternative treatment approaches.

Age is another factor. GLP-1 medications for weight management are approved for adults 18 and older. Semaglutide (Wegovy) also has FDA approval for adolescents aged 12 and older with obesity, though this is typically managed through pediatric specialists rather than telehealth platforms. At Weight Method, we evaluate patients 18 and older for GLP-1 treatment.

The process begins with a comprehensive health assessment. At Weight Method, you complete an online questionnaire covering your height, weight, medical history, current medications, allergies, and health goals. This assessment takes approximately 5-10 minutes and provides your care team with the clinical information needed to make a prescribing decision.

A licensed provider — a physician or nurse practitioner licensed in your state — reviews your assessment. They calculate your BMI, evaluate your medical history for contraindications, and determine the most appropriate medication and starting dose. For patients with a BMI under 35, semaglutide is typically the first-line recommendation. For patients with a BMI of 35 or higher, or those with type 2 diabetes, tirzepatide may offer greater benefit based on clinical trial data showing up to 22.5% body weight reduction.

Once approved, your prescription is sent to a licensed pharmacy that prepares and ships your medication directly to your home. Your first shipment typically arrives within 3-5 business days. The starting dose is always the lowest available — 0.25 mg weekly for semaglutide, 2.5 mg weekly for tirzepatide — with gradual increases every 4 weeks as tolerated. Your provider manages dose escalation based on your response and side effect profile.

One of the most common concerns about getting a GLP-1 prescription online is whether it is safe and legitimate. The answer is yes — when you use a reputable telehealth platform that employs licensed providers and follows established clinical protocols. Telehealth is not a loophole; it is a regulated form of healthcare delivery recognized by every state medical board in the country.

The FDA has been clear that the medications themselves are identical whether prescribed online or in person. What matters is the quality of the medical evaluation and the ongoing supervision. Red flags to watch for include platforms that guarantee a prescription before evaluating you, those that skip the medical history review, or providers who are not willing to disclose their credentials and state licensure.

At Weight Method, every prescription involves a genuine medical evaluation by a credentialed provider. We maintain medical records, document clinical decision-making, and provide ongoing care including dose management and side effect monitoring. Patients have direct access to their care team for questions between scheduled check-ins. This level of medical oversight is what distinguishes legitimate telehealth prescribing from questionable direct-to-consumer operations.

Cost is often the deciding factor for patients considering telehealth GLP-1 prescriptions. Brand-name semaglutide (Wegovy) retails for approximately $1,350 per month, while brand-name tirzepatide (Zepbound) lists at around $1,060 per month. Most patients without comprehensive insurance coverage find these prices prohibitive.

Telehealth platforms that work with compounding pharmacies can offer GLP-1 medications at substantially lower prices. At Weight Method, semaglutide subscriptions start at $297 per month and tirzepatide at $349 per month. These prices include the medication, the initial medical evaluation, ongoing provider access, and dose management — there are no hidden fees or separate consultation charges.

Compared to the traditional route of seeing an in-person weight loss specialist ($200-400 per office visit) plus retail pharmacy pricing ($900-1,350 per month for medication), telehealth GLP-1 subscriptions represent savings of 60-75%. Many patients find that a single monthly subscription replaces what would otherwise require multiple appointments, separate pharmacy trips, and significantly higher out-of-pocket costs.